PMLiVE13h
AbbVie and Xilio announce immunotherapy partnership worth over $2.1bn
AbbVie and Xilio Therapeutics have announced a partnership worth over $2.1bn to develop tumour-activated, antibody-based immunotherapies. The collaboration and option-to-licence agreement will include ...
PMLiVE13h
GSK’s five-in-one meningococcal vaccine Penmenvy granted FDA approval
GSK’s five-in-one meningococcal vaccine Penmenvy has been approved by the US Food and Drug Administration (FDA) for use in ...
PMLiVE13h
Pfizer/Astellas share positive phase 3 results for Padcev in bladder cancer
The approvals were based on positive results from EV-302, in which Padcev plus Keytruda resulted in statistically significant ...
PMLiVE13h
Sobi receives MHRA approval for Altuvoct in severe or moderate haemophilia A
Sobi’s Sanofi-partnered efanesoctocog alfa has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA ...